https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20232024-12-19https://www.crosstreecapital.com/newsroom/crosstree-redefines-brand-image-and-unveils-enhanced-strategic-consulting-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(81)-1.pngUntitled design (81)-1Untitled design (81)-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_98249666-scaled-1.jpegAdobeStock_98249666-scaled-1AdobeStock_98249666-scaled-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-03-21https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20212024-12-19https://www.crosstreecapital.com/insights/events/lp/acmg2025-02-11https://www.crosstreecapital.com/deals/alpha-irb-acquired-by-sabai-global-a-portfolio-company-of-thompson-street-capital-to-expand-irb-capabilities2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20242025-01-21https://www.crosstreecapital.com/insights/events/thanks/world-vaccine-congress2025-04-08https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20202024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20212024-12-19https://www.crosstreecapital.com/deals/synthetech-acquired-by-grace-september-13-20102025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-december-20242025-03-18https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20232024-12-19https://www.crosstreecapital.com/insights/events/tri-con2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-march-20192024-12-19https://www.crosstreecapital.com/insights/events/jpm2024-12-31https://www.crosstreecapital.com/insights/events/thanks/vive2025-01-08https://www.crosstreecapital.com/deals/quartesian-acquired-by-summit-partners-to-form-new-global-outsourced-medtech-provider2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-november-20242025-01-06https://www.crosstreecapital.com/deals/yecuris-acquired-by-janvier-group2025-01-22https://www.crosstreecapital.com/deals/phenopath-has-been-acquired-by-quest-diagnostics-september-20182025-01-22https://www.crosstreecapital.com/deals/imp-logistics-acquired-by-pra-and-genstar-capital-llc-march-4-2013-22025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20222024-12-19https://www.crosstreecapital.com/deals/accel-research-sites-network-acquired-by-alcanza-clinical-research-a-portfolio-company-of-martis-capital-to-expand-its-clinical-trial-site-network-and2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20202024-12-19https://www.crosstreecapital.com/insights/events/beckers-annual-meeting2025-03-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-march-20192024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-november-20242025-01-21https://www.crosstreecapital.com/insights/events/acg-florida-capital-connection2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20222024-12-19https://www.crosstreecapital.com/deals/grenova-completes-growth-recapitalization-with-peloton-equity-to-accelerate-strategic-objectives2025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20232024-12-19https://www.crosstreecapital.com/deals/ascent-and-pharmalex-merge-to-expand-clinical-development-services-in-asia2025-01-22https://www.crosstreecapital.com/deals/pacific-physicians-laboratory-inc-acquired-by-labcorp-december-11-20122025-01-22https://www.crosstreecapital.com/insights/events/thanks/cphi-americas2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20212024-12-19https://www.crosstreecapital.com/insights/events/world-vaccine-congress2025-04-08https://www.crosstreecapital.com/deals/pharmasol-acquired-by-pharmalex-to-offer-turnkey-end-to-end-pharmacovigilance-solutions2025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20202024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-february-20252025-03-26https://www.crosstreecapital.com/newsroom/crosstree-announces-sale-of-sao-buy-side-division-to-7sage-partnershttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/7Sage%20Icons-02.png7Sage Icons-027Sage Icons-022026-07-29https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-february-20252025-03-26https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20202024-12-19https://www.crosstreecapital.com/insights/events/lp/bio-it-world-venture2025-02-11https://www.crosstreecapital.com/deals/realtime-software-solutions-receives-strategic-investment-from-llr-partners-to-accelerate-growth-and-product-innovation2025-01-22https://www.crosstreecapital.com/insights/events/sitc2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-20212024-12-19https://www.crosstreecapital.com/newsroom/crosstree-continues-rapid-expansion-with-first-chief-marketing-and-growth-officer-and-three-new-directorshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_98249666-scaled-1.jpegAdobeStock_98249666-scaled-1AdobeStock_98249666-scaled-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(81)-1.pngUntitled design (81)-1Untitled design (81)-12024-01-09https://www.crosstreecapital.com/insights/events/lp/wrib2025-03-19https://www.crosstreecapital.com/insights/events/lp/dia-eu2025-02-11https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20202024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20192024-12-19https://www.crosstreecapital.com/white-paper2024-07-29https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20202024-12-19https://www.crosstreecapital.com/deals/bct-recapitalized-by-martis-capital-via-its-newly-formed-clinical-research-site-platform-alcanza-clinical-research2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20212024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20242025-01-21https://www.crosstreecapital.com/deals/mprove-health-acquired-by-bracket-october-24-20172025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-january-20192024-12-19https://www.crosstreecapital.com/insights/events/thanks/dpharm2024-09-09https://www.crosstreecapital.com/deals/durbin-acquired-pharmaceutical-trade-services-inc-ptsi-december-1-20142025-01-22https://www.crosstreecapital.com/deals/chemical-computing-group-received-a-majority-investment-from-altaris-june-8-20172025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20232024-12-19https://www.crosstreecapital.com/deals/santus-laboratories-owned-by-healthedge-partners-sold-cough-cold-asset-to-reliable1-august-20182025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20212024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-sept-2019-22024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20212024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20202024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-20212024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20192024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-december-2019-22024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-january-20252025-03-26https://www.crosstreecapital.com/insights/events/lp2024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-sept-2019-22024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharma-technology-bluebook-february-20252025-03-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20232024-12-19https://www.crosstreecapital.com/insights/events/dealmax2025-02-10https://www.crosstreecapital.com/insights/events/thanks/beckers-annual-meeting2025-03-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20242025-01-21https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20242024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-march-20252025-04-16https://www.crosstreecapital.com/insights/events/lp/aaps2024-10-01https://www.crosstreecapital.com/insights/events/lp/tri-con2024-11-15https://www.crosstreecapital.com/deals/fountain-medical-development-fmd-merged-with-kl-consulting-services-september-1-20142025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-february-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20232024-12-19https://www.crosstreecapital.com/insights/events/bio-it-world-venture2025-02-11https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20192024-12-19https://www.crosstreecapital.com/insights/events/thanks/rsna2024-11-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-2024-crosstree2025-01-21https://www.crosstreecapital.com/deals/micronics-raised-6m-in-series-b-preferred-shares-october-16-20082025-01-22https://www.crosstreecapital.com/deals/clairvest-acquires-boca-biolistics-to-accelerate-growth-of-infectious-disease-and-oncological-biobanking-capabilities2025-01-22https://www.crosstreecapital.com/deals/trifecta-clinical-was-acquired-by-wcg2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20242025-01-21https://www.crosstreecapital.com/insights/events/asmebias-axs25-summit2025-03-19https://www.crosstreecapital.com/insights/events/thanks/ashg-annual-meeting2024-10-01https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20212024-12-19https://www.crosstreecapital.com/deals/ducere-pharma-acquired-by-dr-reddys-may-25-20162025-01-22https://www.crosstreecapital.com/deals/anteris-acquired-by-kymanox-a-portfolio-company-of-westview-capital-partners-to-expand-injectable-combination-product-development-capabilities-globall2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20242024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20212024-12-19https://www.crosstreecapital.com/deals/bbk-worldwide-acquired-by-publicis-health-to-expand-clinical-trial-expertise-with-proprietary-technology-and-patient-centric-solutions2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20222024-12-19https://www.crosstreecapital.com/deals/dataceutics-has-been-acquired-by-navitas-life-sciences-a-take-solutions-company2025-01-22https://www.crosstreecapital.com/insights/events/lp/global-site-solutions-summit2024-09-09https://www.crosstreecapital.com/insights/events/lp/dcat-week2025-02-11https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20222024-12-19https://www.crosstreecapital.com/insights/events/thanks/scope-summit2024-11-01https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20232024-12-19https://www.crosstreecapital.com/what-we-do/recapitalizationhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Chronometriq%20-%20fi.png2024 - Chronometriq - fi2024 - Chronometriq - fihttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-Epharmasolutions%20-%20WCG.png2024 -Epharmasolutions - WCG2024 -Epharmasolutions - WCGhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Open%20Clinica%20-%20Thompson%20Street%20(1).png2024 - Open Clinica - Thompson Street (1)2024 - Open Clinica - Thompson Street (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Micronics.png2024 - Micronics2024 - Micronicshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Gentiae%20-%20Baby%20City%20Capital.png2024 - Gentiae - Baby City Capital2024 - Gentiae - Baby City Capitalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Chemical%20Computing%20group%20-%20Altaris.png2024 - Chemical Computing group - Altaris2024 - Chemical Computing group - Altarishttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Medsphere%20-%20Placement%20Agent.png2024 - Medsphere - Placement Agent2024 - Medsphere - Placement Agenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Digital%20Healthcare%20-%20Placement%20Agent%20(2)%20(1).png2024 - Digital Healthcare - Placement Agent (2) (1)2024 - Digital Healthcare - Placement Agent (2) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20UpStream%20-%20Dragoneer.png2024 - UpStream - Dragoneer2024 - UpStream - Dragoneerhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OmniSeq%20-%20LabCorp.png2024 - OmniSeq - LabCorp2024 - OmniSeq - LabCorphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Biorasi%20-%20Riordan%2c%20Lewis%20&%20Haden.png2024 - Biorasi - Riordan, Lewis & Haden2024 - Biorasi - Riordan, Lewis & Hadenhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/What%20We%20Do%20-%20Recap1.jpgWhat We Do - Recap1What We Do - Recap1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OmniSeq%20-%20Hitachi.png2024 - OmniSeq - Hitachi2024 - OmniSeq - Hitachihttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Realtime%20Clinical%20Trial%20-%20LLR%20Partners.png2024 - Realtime Clinical Trial - LLR Partners2024 - Realtime Clinical Trial - LLR Partnershttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Romark%20Laboratories%20-%20Placement%20Agent%20(2)%20(1).png2024 - Romark Laboratories - Placement Agent (2) (1)2024 - Romark Laboratories - Placement Agent (2) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20WCG%20-%20LGP.png2024 - WCG - LGP2024 - WCG - LGPhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Romark%20Laboratories%20-%20Placement%20Agent%20(2).png2024 - Romark Laboratories - Placement Agent (2)2024 - Romark Laboratories - Placement Agent (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20NaviNet%20-%20Placement%20Agent.png2024 - NaviNet - Placement Agent2024 - NaviNet - Placement Agenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Recapitaliztion.jpegRecapitaliztionRecapitaliztionhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Endpoint%20-%20Chiltern.png2024 - Endpoint - Chiltern2024 - Endpoint - Chilternhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Scandius%20-%20Placement%20Agent.png2024 - Scandius - Placement Agent2024 - Scandius - Placement Agenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Bridge%20-%20Aisling%20Capital.png2024 - Bridge - Aisling Capital2024 - Bridge - Aisling Capital2024-12-31https://www.crosstreecapital.com/white-paper/white-paperpatient-access-organizations-an-emerging-ecosystem2024-09-12https://www.crosstreecapital.com/insights/events/cphi-americas2025-03-19https://www.crosstreecapital.com/deals/cliniqa-acquired-by-bio-techne-july-9-20152025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20202024-12-19https://www.crosstreecapital.com/deals/healthcare-discoveries-acquired-by-icon-february-11-20082025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20232024-12-19https://www.crosstreecapital.com/deals/pyxant-labs-bolsters-capabilities-in-acquisition-of-covance-by-labcorps-slc-bioanalytical-site2025-01-22https://www.crosstreecapital.com/deals/senova-systems-acquired-by-parker2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-may-20192024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-december-20242025-01-21https://www.crosstreecapital.com/insights/events/lp/himss2025-01-08https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-november-20242025-01-06https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20222024-12-19https://www.crosstreecapital.com/careers/openpositionshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstree_bg_abstractcrosstree_bg_abstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-12-31https://www.crosstreecapital.com/deals/prophase-acquired-by-wcg-and-arsenal-capital-partners-may-9-20172025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20212024-12-19https://www.crosstreecapital.com/deals/access-regional-laboratory-business-acquired-by-labcorp-june-20172025-01-22https://www.crosstreecapital.com/deals/gsk-is-selling-assets-to-foundation-consumer-healthcare2025-01-22https://www.crosstreecapital.com/deals/velos-acquired-wcg-a-portfolio-company-of-arsenal-capital-partners2025-01-22https://www.crosstreecapital.com/deals/sigmacare-acquired-by-homecare-crm-march-10-20152025-01-22https://www.crosstreecapital.com/article/surfing-the-wave-the-patient-data-puzzlehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle-2NewArticle-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb-2021-ContentFeb-2021-Contenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrows_Orange2Arrows_Orange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-01-09https://www.crosstreecapital.com/insights/events/scope-summit2024-12-31https://www.crosstreecapital.com/insights/events/lp/beckers-annual-meeting2025-03-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-february-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-2019-22024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20192024-12-19https://www.crosstreecapital.com/deals/clinical-pharmacology-of-miami-acquired-by-evolution-research-group2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20212024-12-19https://www.crosstreecapital.com/deals/cytolab-pathology-services-acquired-by-labcorp-december-11-20122025-01-22https://www.crosstreecapital.com/insights/events/lp/beckers-healthcare-health-it-digital-health-rcm-conference2024-09-09https://www.crosstreecapital.com/market-map/theprismdoctrinehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovations-Book-Feature-Image-for-website-1-scaledInnovations-Book-Feature-Image-for-website-1-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism-1800x1200Prism-1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-01-09https://www.crosstreecapital.com/deals/pht-acquired-by-ert-and-genstar-capital-may-11-20152025-01-22https://www.crosstreecapital.com/insights/events/thanks/aacr2025-03-19https://www.crosstreecapital.com/insights/events/thanks/jpm2024-11-01https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20232024-12-19https://www.crosstreecapital.com/insights/events/ahima-24-conference2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-20202024-12-19https://www.crosstreecapital.com/insights/events/lp/amp-annual-meeting-and-expo2024-11-18https://www.crosstreecapital.com/deals/chemo-assets-acquired-by-ducere-pharma2025-01-22https://www.crosstreecapital.com/insights/events/thanks/pegs-europe2024-10-01https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20242025-01-21https://www.crosstreecapital.com/deals/romark-laboratories-amount-raised-undisclosed2025-01-22https://www.crosstreecapital.com/deals/ssi-strategy-a-portfolio-company-of-amulet-capital-partners-acquired-nda-group-ab-to-bolster-regulatory-affairs-consulting-capabilities-and-expand-int2025-01-22https://www.crosstreecapital.com/videos/covid-19-impact-on-pharma-development-innovation-with-steve-sullivanhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRick-Riegel-Still-2Rick-Riegel-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-01-09https://www.crosstreecapital.com/insights/events/amp-annual-meeting-and-expo2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20232024-12-19https://www.crosstreecapital.com/deals/genstar-capital-acquires-advarra-from-linden-partners2025-01-22https://www.crosstreecapital.com/deals/radiant-research-acquired-by-icici-venture-june-8-20072025-01-22https://www.crosstreecapital.com/deals/infopro-acquired-by-aptuit-november-14-20052025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20232024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20202024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-june-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20202024-12-19https://www.crosstreecapital.com/about/team/sara-casamento2026-02-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20242025-01-21https://www.crosstreecapital.com/insights/eventshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-10-01T121313.042.pngUntitled design - 2024-10-01T121313.042Untitled design - 2024-10-01T121313.042https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-01T103926.358.pngUntitled design - 2024-11-01T103926.358Untitled design - 2024-11-01T103926.358https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-08T112429.317.pngUntitled design - 2025-01-08T112429.317Untitled design - 2025-01-08T112429.317https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-19T111642.502.pngUntitled design - 2025-03-19T111642.502Untitled design - 2025-03-19T111642.502https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T145900.585.pngUntitled design - 2024-09-23T145900.585Untitled design - 2024-09-23T145900.585https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-08T143859.490.pngUntitled design - 2025-04-08T143859.490Untitled design - 2025-04-08T143859.490https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T125609.141.pngUntitled design - 2024-08-29T125609.141Untitled design - 2024-08-29T125609.141https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T144347.826.pngUntitled design - 2024-09-23T144347.826Untitled design - 2024-09-23T144347.826https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-11T164817.019.pngUntitled design - 2025-02-11T164817.019Untitled design - 2025-02-11T164817.019https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-11T170828.896.pngUntitled design - 2025-02-11T170828.896Untitled design - 2025-02-11T170828.896https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T130232.151.pngUntitled design - 2024-08-29T130232.151Untitled design - 2024-08-29T130232.151https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-19T115408.077.pngUntitled design - 2025-03-19T115408.077Untitled design - 2025-03-19T115408.077https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-11T170500.135.pngUntitled design - 2025-02-11T170500.135Untitled design - 2025-02-11T170500.135https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T125134.154.pngUntitled design - 2024-08-29T125134.154Untitled design - 2024-08-29T125134.154https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T143707.101.pngUntitled design - 2024-09-23T143707.101Untitled design - 2024-09-23T143707.101https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T130644.160.pngUntitled design - 2024-08-29T130644.160Untitled design - 2024-08-29T130644.160https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-18T145326.777.pngUntitled design - 2024-11-18T145326.777Untitled design - 2024-11-18T145326.777https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T124544.883.pngUntitled design - 2024-08-29T124544.883Untitled design - 2024-08-29T124544.883https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T142903.167.pngUntitled design - 2024-09-23T142903.167Untitled design - 2024-09-23T142903.167https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-15T121810.962.pngUntitled design - 2024-11-15T121810.962Untitled design - 2024-11-15T121810.962https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-01T144217.760.pngUntitled design - 2024-11-01T144217.760Untitled design - 2024-11-01T144217.760https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-12T162536.396.pngUntitled design - 2024-11-12T162536.396Untitled design - 2024-11-12T162536.396https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-01T142250.750.pngUntitled design - 2024-11-01T142250.750Untitled design - 2024-11-01T142250.7502024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20242024-12-19https://www.crosstreecapital.com/insights/events/thanks/hlth2024-09-09https://www.crosstreecapital.com/insights/events/lp/hlth2024-09-09https://www.crosstreecapital.com/insights/events/lp/world-drug-safety-congress-americas-20242024-09-23https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-november-20212024-12-19https://www.crosstreecapital.com/deals/candescent-healing-acquired-by-candescent-partners2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20202024-12-19https://www.crosstreecapital.com/deals/pacific-data-designs-acquired-by-dw-healthcare-partners-november-6-20082025-01-22https://www.crosstreecapital.com/videoshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRick-Riegel-Still-2Rick-Riegel-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/no-challenges-thumbnail.jpgno-challenges-thumbnailno-challenges-thumbnailhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-22024-01-09https://www.crosstreecapital.com/deals/pmi-preclinical-was-acquired-by-covance-a-subsidiary-of-labcorp-october-20182025-01-22https://www.crosstreecapital.com/deals/clinical-site-services-acquired-by-american-clinical-research-services-to-add-tech-enabled-patient-recruitment-capabilities2025-01-22https://www.crosstreecapital.com/insights/events/thanks/amp-annual-meeting-and-expo2024-11-18https://www.crosstreecapital.com/insights/events/lp/sitc2024-11-01https://www.crosstreecapital.com/newsroomhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_email.svgicon_emailicon_emailhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(81)-1.pngUntitled design (81)-1Untitled design (81)-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_238800457.jpegAdobeStock_238800457AdobeStock_238800457https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_98249666-scaled-1.jpegAdobeStock_98249666-scaled-1AdobeStock_98249666-scaled-12024-01-09https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20232024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20202024-12-19https://www.crosstreecapital.com/insights/events/thanks/cphi-worldwide2024-09-09https://www.crosstreecapital.com/deals/bridge-laboratories-raised-35m-in-series-b-preferred-shares-from-aisling-capital-and-lehman-brothers-june-14-20062025-01-22https://www.crosstreecapital.com/deals/array-biostatistics-was-acquired-by-cato-sms2025-01-22https://www.crosstreecapital.com/insights/events/thanks/sitc2024-11-01https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-192024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20242025-01-21https://www.crosstreecapital.com/deals/pharmica-consulting-acquired-by-propharma-group-to-provide-holistic-clinical-trial-execution-expertise2025-01-22https://www.crosstreecapital.com/about/team/gordonryerson2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20242024-12-19https://www.crosstreecapital.com/deals/intrinsic-clinical-systems-acquired-by-propharma-group2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-january-20252025-03-26https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20232024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-march-20252025-04-14https://www.crosstreecapital.com/deals/trevigen-acquired-by-bio-techne-september-5-20172025-01-22https://www.crosstreecapital.com/deals/physiq-acuired-by-prolaio2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20212024-12-19https://www.crosstreecapital.com/insights/events/himss2025-01-08https://www.crosstreecapital.com/insights/events/world-vaccine-congress-europe2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20202024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-january-20252025-03-26https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20222024-12-19https://www.crosstreecapital.com/deals/mo-bio-acquired-by-qiagen-january-11-20162025-01-22https://www.crosstreecapital.com/insights/events/cphi-worldwide2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20202024-12-19https://www.crosstreecapital.com/deals/baylor-college-of-medicine-bdc-assets-acquired-by-cell-medica-june-17-20162025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20202024-12-19https://www.crosstreecapital.com/insights/events/lp/pharma-ci-conference2024-09-23https://www.crosstreecapital.com/insights/events/thanks/slas2024-11-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharma-technology-bluebook-january-20252025-03-18https://www.crosstreecapital.com/insights/events/dcat-week2025-02-11https://www.crosstreecapital.com/deals/biocor-acquired-by-ubc-november-6-20062025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20212024-12-19https://www.crosstreecapital.com/deals/versiti-acquired-pearl-pathways-to-expand-clinical-trial-services-capabilities2025-01-22https://www.crosstreecapital.com/insights/events/thanks/pharma-ci-conference2024-09-23https://www.crosstreecapital.com/insights/events/lp/slas2024-11-15https://www.crosstreecapital.com/deals/haematologic-technologies-inc-was-acquired-by-edgewater-capital-partners2025-01-22https://www.crosstreecapital.com/deals/cmdx-financial-advisory2025-01-22https://www.crosstreecapital.com/deals/biorasi-received-a-majority-investment-from-riordan-lewis-haden-equity-partners-november-16-20182025-01-22https://www.crosstreecapital.com/deals/invivodata-acquired-by-ert-and-genstar-capital-llc-july-9-20122025-01-22https://www.crosstreecapital.com/deals/digital-healthcare-raised-3000000-preferred-stock-through-a-placement-agent2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-march-20252025-04-16https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-2019-22024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-june-20192024-12-19https://www.crosstreecapital.com/insights/events/lp/aaps-national-biotechnology-conference2025-03-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-december-20242025-01-21https://www.crosstreecapital.com/deals/medifacts-international-acquired-by-global-research-services-march-23-20072025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-december-2019-22024-12-19https://www.crosstreecapital.com/insights/events/thanks/snmmi2025-03-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-may-20192024-12-19https://www.crosstreecapital.com/deals/molecularmd-has-been-acquired-by-icon-plc2025-01-22https://www.crosstreecapital.com/deals/citoxlab-acquired-solvo-biotechnology-march-12-20182025-01-22https://www.crosstreecapital.com/deals/aj-home-care-inc-acquired-by-hcs2025-01-22https://www.crosstreecapital.com/insights/events/rsna2024-12-31https://www.crosstreecapital.com/insights/events/thanks/bio-it-world-venture2025-02-11https://www.crosstreecapital.com/deals/upstream-completes-45-million-funding-round-led-by-dragoneer-to-revolutionize-care-for-older-adults2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20242024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-march-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20242025-01-21https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-january-20252025-03-18https://www.crosstreecapital.com/deals/medisync-acquired-by-vyteris-april-18-20112025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-november-20222024-12-19https://www.crosstreecapital.com/deals/aptilon-acquired-by-indegene-november-9-20122025-01-22https://www.crosstreecapital.com/deals/ttm-acquired-by-indegene-january-2-20142025-01-22https://www.crosstreecapital.com/insights/events/cns-summit2024-12-31https://www.crosstreecapital.com/deals/clinical-pharmacology-associates-acquired-by-sfbc-international-august-4-2003-22025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-april-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20242024-12-19https://www.crosstreecapital.com/insights/events/lp/sot2024-11-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20242025-01-21https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-january-20252025-03-26https://www.crosstreecapital.com/deals/cri-worldwide-acquired-by-sv-life-sciences-october-3-20072025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20192024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-march-20252025-04-16https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20232024-12-19https://www.crosstreecapital.com/deals/h-i-g-capital-acquires-majority-stake-in-navitas-life-sciences-to-accelerate-cro-growth2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20242025-01-21https://www.crosstreecapital.com/deals/martec-acquired-by-nostrum-december-20-20062025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-august-20192024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20212024-12-19https://www.crosstreecapital.com/deals/viactiv-acquired-by-adare-and-tpg2025-01-22https://www.crosstreecapital.com/deals/datalabs-acquired-by-clinphone-october-27-20062025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20202024-12-19https://www.crosstreecapital.com/insights/events/vive2025-01-08https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20222024-12-19https://www.crosstreecapital.com/insights/events/thanks/aaps-national-biotechnology-conference2025-03-19https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-march-20252025-04-16https://www.crosstreecapital.com/deals/biosafe-raised-6500000-subordinated-debt-through-a-placement-agent2025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20232024-12-19https://www.crosstreecapital.com/deals/clintrak-acquired-by-fisher-scientific-international-inc-april-11-20062025-01-22https://www.crosstreecapital.com/deals/histogenex-combines-with-caprion-biosciences-via-strategic-investment-from-arsenal-capital-partners2025-01-22https://www.crosstreecapital.com/deals/access-medical-labs-allies-with-grupo-diagnostico-aries-to-expand-diagnostic-lab-capabilities-into-north-america2025-01-22https://www.crosstreecapital.com/deals/pyxant-labs-receives-majority-investment-from-archimed2025-01-22https://www.crosstreecapital.com/deals/transposagen-biopharmaceuticals-inc-has-been-acquired-by-lonza2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20202024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-february-20252025-03-26https://www.crosstreecapital.com/insights/events/sot2024-12-31https://www.crosstreecapital.com/deals/dmd-acquired-by-aptilon-september-18-20092025-01-22https://www.crosstreecapital.com/deals/openclinica-completes-growth-recapitalization-with-thompson-street-capital-partners-to-accelerate-enablement-of-clinical-trials2025-01-22https://www.crosstreecapital.com/deals/pbi-financial-advisory2025-01-22https://www.crosstreecapital.com/deals/grant-avenue-capital-recapitalizes-creo2025-01-22https://www.crosstreecapital.com/insights/events/lp/world-vaccine-congress-europe2024-09-23https://www.crosstreecapital.com/deals/bioagilytix-labs-acquired-by-riverside-partners-june-4-20132025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20222024-12-19https://www.crosstreecapital.com/deals/converge-acquired-by-quest-diagnostics-october-7-20132025-01-22https://www.crosstreecapital.com/about/team/gregorybare2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20232024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-sept-2019-22024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20242024-12-19https://www.crosstreecapital.com/contacthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstree_bg_abstractcrosstree_bg_abstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2026-02-24https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-december-20242025-01-21https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-january-20192024-12-19https://www.crosstreecapital.com/deals/ils-genomics-acquired-by-labcorp-july-31-20152025-01-22https://www.crosstreecapital.com/video/industry-leaders-panel-discussion-patient-access-organizations2024-09-24https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20222024-12-19https://www.crosstreecapital.com/insights/events/hlth2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20212024-12-19https://www.crosstreecapital.com/insights/events/thanks/ahima-24-conference2024-09-23https://www.crosstreecapital.com/insights/events/lp/vive2025-01-08https://www.crosstreecapital.com/case-studyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpgcrosstree-og-image-Jan-02-2024-04-39-57-4666-PMcrosstree-og-image-Jan-02-2024-04-39-57-4666-PM2024-01-08https://www.crosstreecapital.com/deals/vaxtrials-acuired-by-emmes2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-may-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-october-192024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20212024-12-19https://www.crosstreecapital.com/deals/mdci-acquired-by-aptiv-solutions-and-sv-life-sciences-august-22-20112025-01-22https://www.crosstreecapital.com/subscribehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/banner_subscribe.jpgbanner_subscribebanner_subscribe2024-08-09https://www.crosstreecapital.com/deals/ipeople-acquired-by-rldatix-a-portfolio-company-of-five-arrows-and-ta-associates2025-03-18https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-october-192024-12-19https://www.crosstreecapital.com/insights/events/thanks/chime-innovation-summit-southeast2025-03-19https://www.crosstreecapital.com/bluebooks2024-02-14https://www.crosstreecapital.com/insights/events/slas2024-12-31https://www.crosstreecapital.com/deals/plethico-acquired-natrol-december-28-20072025-01-22https://www.crosstreecapital.com/insights/events/lp/snmmi2025-03-19https://www.crosstreecapital.com/deals/gentiae-raised-16m-in-series-b-preferred-shares-from-bay-city-capital-and-cibc-january-3-20072025-01-22https://www.crosstreecapital.com/insights/events/thanks/asmebias-axs25-summit2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20232024-12-19https://www.crosstreecapital.com/insights/events/lp/cphi-americas2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20242024-12-19https://www.crosstreecapital.com/insights/events/lp/rsna2024-11-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20222024-12-19https://www.crosstreecapital.com/deals/firstsource-laboratory-solutions-acquired-by-labcorp-september-14-20102025-01-22https://www.crosstreecapital.com/insights/events/thanks/dcat-week2025-02-11https://www.crosstreecapital.com/deals/atherotech-financial-advisory2025-01-22https://www.crosstreecapital.com/deals/semorex-acquired-by-myos-corporation2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20212024-12-19https://www.crosstreecapital.com/deals/chonometriq-received-an-investment-from-full-in-partners-october-1-20192025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20222024-12-19https://www.crosstreecapital.com/deals/tulip-group-acquired-by-perkinelmer-january-9-20172025-01-22https://www.crosstreecapital.com/deals/pharmaceutical-profiles-acquired-by-quotient-bioscience-december-15-20082025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20212024-12-19https://www.crosstreecapital.comhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Hompage%20V3.jpgHompage V3Hompage V3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep 6 AITempus (315 x 315 px)Deep 6 AITempus (315 x 315 px)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDeal Insight Campaign Tombstone - BBIIBEXDeal Insight Campaign Tombstone - BBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-17T150049.946.pngUntitled design - 2025-03-17T150049.946Untitled design - 2025-03-17T150049.946https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-22T150033.284.pngUntitled design - 2025-04-22T150033.284Untitled design - 2025-04-22T150033.284https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDeal Insight Campaign Tombstone - Calyx (Social Sized).V3-1Deal Insight Campaign Tombstone - Calyx (Social Sized).V3-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDeal Insight Campaign LVCCRCNJ - SocialDeal Insight Campaign LVCCRCNJ - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024 - Vax Trials - Emmes2024 - Vax Trials - Emmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-SizedDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDeal Insight Campaign Myonex + Creapharm- Social V2 (1)Deal Insight Campaign Myonex + Creapharm- Social V2 (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T103632.637.pngUntitled design - 2025-04-16T103632.637Untitled design - 2025-04-16T103632.637https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDeal Insight Tombstone sengenics (2)Deal Insight Tombstone sengenics (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDeal Insight Campaign Myonex + Creapharm- Social V2Deal Insight Campaign Myonex + Creapharm- Social V2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024 - Versiti - Pearl Pathways2024 - Versiti - Pearl Pathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_test-tube.svgicon_test-tubeicon_test-tubehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-14T103931.881.pngUntitled design - 2025-04-14T103931.881Untitled design - 2025-04-14T103931.881https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDeal Insight Tombstone ActiGraph (1)Deal Insight Tombstone ActiGraph (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDeal Insight Campaign Tombstone - Continuum Clinical (Social Sized)Deal Insight Campaign Tombstone - Continuum Clinical (Social Sized)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_microscope-list.svgicon_microscope-listicon_microscope-listhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDeal Insight Tombstone BiotechneDeal Insight Tombstone Biotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/ROI%20Healthcare%20Deal%20Featured%20Image%20(1).pngROI Healthcare Deal Featured Image (1)ROI Healthcare Deal Featured Image (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDeal Insight Tombstone iPeople (3)Deal Insight Tombstone iPeople (3)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDeal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)Deal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDeal Insight Tombstone Anju + ValsoftDeal Insight Tombstone Anju + Valsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDeal Insight Campaign LVCKerwin - SocialDeal Insight Campaign LVCKerwin - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_health-phone.svgicon_health-phoneicon_health-phonehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Recapitaliztion.jpegRecapitaliztionRecapitaliztionhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20Advisory.jpgM&A AdvisoryM&A Advisoryhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDeal Campaign Tombstone - PhysIQ (Social Sized) (1)Deal Campaign Tombstone - PhysIQ (Social Sized) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstone_ROI_01_28_2026-1Tombstone_ROI_01_28_2026-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T110543.792.pngUntitled design - 2025-04-16T110543.792Untitled design - 2025-04-16T110543.792https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024-ModularDevices-Flow2024-ModularDevices-Flowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20Servicesv2.jpgValue Creation Servicesv2Value Creation Servicesv22025-03-11https://www.crosstreecapital.com/deals/enthalpy-bioanalytical-testing-division-acquired-by-labcorp-june-11-20102025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-february-20192024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20242025-01-21https://www.crosstreecapital.com/deals/biomain-acquired-by-heraeus-march-1-20122025-01-22https://www.crosstreecapital.com/deals/myonex-acquired-saveway-compounding-pharmacy2025-03-18https://www.crosstreecapital.com/deals/pinnacle-clinical-research-a-portfolio-company-of-longuevue-capital-acquired-the-cognitive-and-research-center-of-new-jersey-to-expand-clinical-trial-site-network-to-expand-its-cns-trial-execution-capabilities2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20242024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-january-20252025-03-26https://www.crosstreecapital.com/dealshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDeal Insight Campaign Myonex + Creapharm- Social V2Deal Insight Campaign Myonex + Creapharm- Social V2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024-ModularDevices-Flow2024-ModularDevices-Flowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstone_ROI_01_28_2026-1Tombstone_ROI_01_28_2026-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDeal Insight Campaign Tombstone - BBIIBEXDeal Insight Campaign Tombstone - BBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDeal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)Deal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDeal Insight Campaign LVCCRCNJ - SocialDeal Insight Campaign LVCCRCNJ - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDeal Insight Tombstone ActiGraph (1)Deal Insight Tombstone ActiGraph (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDeal Insight Campaign Tombstone - Calyx (Social Sized).V3-1Deal Insight Campaign Tombstone - Calyx (Social Sized).V3-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDeal Insight Campaign LVCKerwin - SocialDeal Insight Campaign LVCKerwin - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024 - Versiti - Pearl Pathways2024 - Versiti - Pearl Pathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-SizedDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep 6 AITempus (315 x 315 px)Deep 6 AITempus (315 x 315 px)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Client%20Testimonials.jpegClient TestimonialsClient Testimonialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDeal Campaign Tombstone - PhysIQ (Social Sized) (1)Deal Campaign Tombstone - PhysIQ (Social Sized) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDeal Insight Tombstone BiotechneDeal Insight Tombstone Biotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDeal Insight Tombstone sengenics (2)Deal Insight Tombstone sengenics (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDeal Insight Campaign Myonex + Creapharm- Social V2 (1)Deal Insight Campaign Myonex + Creapharm- Social V2 (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDeal Insight Tombstone Anju + ValsoftDeal Insight Tombstone Anju + Valsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024 - Vax Trials - Emmes2024 - Vax Trials - Emmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDeal Insight Tombstone iPeople (3)Deal Insight Tombstone iPeople (3)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDeal Insight Campaign Tombstone - Continuum Clinical (Social Sized)Deal Insight Campaign Tombstone - Continuum Clinical (Social Sized)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-12-31https://www.crosstreecapital.com/focus/healthcare-technologyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pharmica%20-%20Propharma%20Group.png2024 - Pharmica - Propharma Group2024 - Pharmica - Propharma Grouphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_medical-case.svgicon_medical-caseicon_medical-casehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDeal Campaign Tombstone - PhysIQ (Social Sized) (1)Deal Campaign Tombstone - PhysIQ (Social Sized) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(77).pngUntitled design (77)Untitled design (77)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OmniComm%20-%20anju.png2024 - OmniComm - anju2024 - OmniComm - anjuhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_559486634.jpegAdobeStock_559486634AdobeStock_559486634https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstone_ROI_01_28_2026-1Tombstone_ROI_01_28_2026-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Intrinsic%20-%20Propharma%20Group.png2024 - Intrinsic - Propharma Group2024 - Intrinsic - Propharma Grouphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_gear.svgicon_gearicon_gearhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Expertise-Healthcare%20Technology.jpgExpertise-Healthcare TechnologyExpertise-Healthcare Technologyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20PMI%20-%20Covance.png2024 - PMI - Covance2024 - PMI - Covancehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(78).pngUntitled design (78)Untitled design (78)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Trifecta%20-%20WCG.png2024 - Trifecta - WCG2024 - Trifecta - WCGhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Catalyst%20-%20QHP%20-%20Genpro.png2024 - Catalyst - QHP - Genpro2024 - Catalyst - QHP - Genprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20DataCeutics%20%2B%20Navitas.png2024 - DataCeutics + Navitas2024 - DataCeutics + Navitashttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20WCG%20-%20LGP.png2024 - WCG - LGP2024 - WCG - LGPhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDeal Insight Tombstone iPeople (3)Deal Insight Tombstone iPeople (3)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDeal Insight Tombstone ActiGraph (1)Deal Insight Tombstone ActiGraph (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20UpStream%20-%20Dragoneer.png2024 - UpStream - Dragoneer2024 - UpStream - Dragoneerhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDeal Insight Campaign Tombstone - Calyx (Social Sized).V3-1Deal Insight Campaign Tombstone - Calyx (Social Sized).V3-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Clinical%20Site%20Services%20-%20ACRS%20-%20Latticework.png2024 - Clinical Site Services - ACRS - Latticework2024 - Clinical Site Services - ACRS - Latticeworkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Protocol%20First%20-%20Flatiron%20-%20Roche.png2024 - Protocol First - Flatiron - Roche2024 - Protocol First - Flatiron - Rochehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDeal Insight Tombstone sengenics (2)Deal Insight Tombstone sengenics (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Velos%20-%20WCG.png2024 - Velos - WCG2024 - Velos - WCGhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/BlueBook%20-%20Health%20Tech.jpgBlueBook - Health TechBlueBook - Health Techhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Virmedica%20-%20CareMetx.png2024 - Virmedica - CareMetx2024 - Virmedica - CareMetxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pharmasol%20-%20Pharmalex.png2024 - Pharmasol - Pharmalex2024 - Pharmasol - Pharmalex2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20242025-01-21https://www.crosstreecapital.com/insights/events/thanks2024-02-14https://www.crosstreecapital.com/deals/anju-software-acquired-by-valsoft-corporation-to-grow-eclinical-and-commercialization-capabilities2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-november-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20232024-12-19https://www.crosstreecapital.com/deals/gsk-sold-assets-to-crown-laboratories2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20202024-12-19https://www.crosstreecapital.com/insights/events/ashg-annual-meeting2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-november-20242025-01-21https://www.crosstreecapital.com/deals/caremetx-owned-by-the-vistria-group-acquired-virmedica-owned-by-petra-capital-partners-september-20182025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20222024-12-19https://www.crosstreecapital.com/insights/events/lp/acg-florida-capital-connection2024-11-12https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-december-20242025-01-21https://www.crosstreecapital.com/deals/santus-laboratories-owned-by-healthedge-partners-was-purchased-by-dermarite-owned-by-tailwind-capital-group-august-20182025-01-22https://www.crosstreecapital.com/insights/events/thanks/wrib2025-03-19https://www.crosstreecapital.com/deals/accelrys-acquired-qumas-december-9-20132025-01-22https://www.crosstreecapital.com/deals/clinchoice-acquires-cromsource-to-expand-cro-capabilities-globally2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20242025-01-21https://www.crosstreecapital.com/deals/bio-techne-divested-assets-of-its-subsidiary-atlanta-biologicals-to-geminibio2025-03-13https://www.crosstreecapital.com/deals/benchmark-research-acquired-by-iqvia-combined-with-avacare-to-expand-vaccine-and-clinical-trial-site-capabilities2025-01-22https://www.crosstreecapital.com/deals/bbi-solutions-a-portfolio-company-of-novo-holdings-acquired-ibex-technologies-inc2025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-february-20252025-03-26https://www.crosstreecapital.com/deals/gentris-acquired-by-cancer-genetics-july-21-20142025-01-22https://www.crosstreecapital.com/deals/preventiongenetics-acquired-by-exact-sciences-to-enable-earlier-cancer-detection-and-hereditary-cancer-testing2025-01-22https://www.crosstreecapital.com/insights/events/thanks/aaps2024-10-01https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20242024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20232024-12-19https://www.crosstreecapital.com/insights/events/thanks/global-site-solutions-summit2024-09-09https://www.crosstreecapital.com/white-paper/thank-you/precision-and-specialty-medicines-impact-on-the-future-of-clinical-trials2024-02-14https://www.crosstreecapital.com/insights/events/thanks/acmg2025-02-11https://www.crosstreecapital.com/what-we-do/strategy-advisory-and-origination-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/VCS%20-%20Add-on.jpgVCS - Add-onVCS - Add-onhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024-ModularDevices-Flow2024-ModularDevices-Flowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pyxant%20Labs%20-%20ArchiMed.png2024 - Pyxant Labs - ArchiMed2024 - Pyxant Labs - ArchiMedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20ClinChoice%20-%20Crom%20Source.png2024 - ClinChoice - Crom Source2024 - ClinChoice - Crom Sourcehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20LVC%20-%20Summit%20Clinical%20Research.png2024 - LVC - Summit Clinical Research2024 - LVC - Summit Clinical Researchhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Flourish%20-%20Excel%20Medical.png2024 - Flourish - Excel Medical2024 - Flourish - Excel Medicalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20-%20Growth.jpgValue Creation - GrowthValue Creation - Growthhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_288913742.jpegAdobeStock_288913742AdobeStock_288913742https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grant%20Avenue%20-%20Creo.png2024 - Grant Avenue - Creo2024 - Grant Avenue - Creohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Catalyst%20-%20QHP%20-%20Genpro.png2024 - Catalyst - QHP - Genpro2024 - Catalyst - QHP - Genprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Quantizen.png2024 - Versiti - Quantizen2024 - Versiti - Quantizenhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Digital%20Healthcare%20-%20Placement%20Agent%20(2).png2024 - Digital Healthcare - Placement Agent (2)2024 - Digital Healthcare - Placement Agent (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20Servicesv2.jpgValue Creation Servicesv2Value Creation Servicesv2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20HIG%20Capital%20-%20NAVITAS.png2024 - HIG Capital - NAVITAS2024 - HIG Capital - NAVITAShttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20SSI%20Strategy%20-%20Amulet%20Capital%20-%20NDA.png2024 - SSI Strategy - Amulet Capital - NDA2024 - SSI Strategy - Amulet Capital - NDAhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024 - Versiti - Pearl Pathways2024 - Versiti - Pearl Pathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Clairvest%20-%20BocaBiolistics.png2024 - Clairvest - BocaBiolistics2024 - Clairvest - BocaBiolisticshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20-%20Strategy.jpgValue Creation - StrategyValue Creation - Strategyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20Services%20-%20Image%201.jpgValue Creation Services - Image 1Value Creation Services - Image 1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20DMed%20-%20Clinipace.png2024 - DMed - Clinipace2024 - DMed - Clinipace2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20212024-12-19https://www.crosstreecapital.com/deals/epharmasolutions-received-a-strategic-investment-from-arsenal-capital-partners-and-wirb-copernicus-group-september-24-20142025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20202024-12-19https://www.crosstreecapital.com/deals/idt-acquired-the-oligo-manufacturing-business-of-geneworks-february-8-20172025-01-22https://www.crosstreecapital.com/deals/pathnet-acquired-by-labcorp-september-28-20082025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20192024-12-19https://www.crosstreecapital.com/insights/events/thanks/dealmax2025-02-10https://www.crosstreecapital.com/deals/curetis-and-opgen-enter-into-definitive-agreement-to-combine-businesses2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20202024-12-19https://www.crosstreecapital.com/white-paper/thank-you/positioning-biobanking-assets-for-maximum-value2024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-december-20242025-01-21https://www.crosstreecapital.com/deals/xenometrics-acquired-by-citoxlab-october-31-20172025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20242024-12-19https://www.crosstreecapital.com/deals/clinical-trials-of-texas-recapitalized-by-nms-capital-to-form-new-flourish-research-clinical-research-site-platform2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20202024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20212024-12-19https://www.crosstreecapital.com/deals/research-point-global-acquired-by-wuxi-apptec-october-17-20172025-01-22https://www.crosstreecapital.com/deals/phoenix-data-systems-acquired-by-bioclinica-formerly-bio-imaging-technologies-april-28-20082025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-march-20202024-12-19https://www.crosstreecapital.com/insights/events/lp/jpm2024-11-01https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20232024-12-19https://www.crosstreecapital.com/deals/ixion-biotechnology-inc-financial-advisory2025-01-22https://www.crosstreecapital.com/focus/pharma-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Benchmark%20Research%20-%20IQVIA.png2024 - Benchmark Research - IQVIA2024 - Benchmark Research - IQVIAhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(75).pngUntitled design (75)Untitled design (75)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDeal Insight Campaign Myonex + Creapharm- Social V2Deal Insight Campaign Myonex + Creapharm- Social V2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep 6 AITempus (315 x 315 px)Deep 6 AITempus (315 x 315 px)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20mbr%20-%20New%20harbor.png2024 - mbr - New harbor2024 - mbr - New harborhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Pharma%20Services.jpegPharma ServicesPharma Serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDeal Insight Campaign Myonex + Creapharm- Social V2 (1)Deal Insight Campaign Myonex + Creapharm- Social V2 (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024-ModularDevices-Flow2024-ModularDevices-Flowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDeal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)Deal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_money.svgicon_moneyicon_moneyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20SSI%20Strategy%20-%20Amulet%20Capital%20-%20NDA.png2024 - SSI Strategy - Amulet Capital - NDA2024 - SSI Strategy - Amulet Capital - NDAhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-SizedDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDeal Campaign Tombstone - PhysIQ (Social Sized) (1)Deal Campaign Tombstone - PhysIQ (Social Sized) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024 - Vax Trials - Emmes2024 - Vax Trials - Emmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Accel%20-%20Alcanza%20-%20Martis%20Capital.png2024 - Accel - Alcanza - Martis Capital2024 - Accel - Alcanza - Martis Capitalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDeal Insight Campaign Tombstone - Continuum Clinical (Social Sized)Deal Insight Campaign Tombstone - Continuum Clinical (Social Sized)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Pharma%20Services%20-%20BlueBook.jpegPharma Services - BlueBookPharma Services - BlueBookhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDeal Insight Tombstone Anju + ValsoftDeal Insight Tombstone Anju + Valsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDeal Insight Campaign LVCCRCNJ - SocialDeal Insight Campaign LVCCRCNJ - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024 - Versiti - Pearl Pathways2024 - Versiti - Pearl Pathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDeal Insight Campaign Tombstone - Calyx (Social Sized).V3-1Deal Insight Campaign Tombstone - Calyx (Social Sized).V3-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_box.svgicon_boxicon_boxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_medical-case.svgicon_medical-caseicon_medical-casehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDeal Insight Campaign LVCKerwin - SocialDeal Insight Campaign LVCKerwin - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Catalyst%20-%20QHP%20-%20Genpro.png2024 - Catalyst - QHP - Genpro2024 - Catalyst - QHP - Genprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_641600188.jpegAdobeStock_641600188AdobeStock_641600188https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grant%20Avenue%20-%20Creo.png2024 - Grant Avenue - Creo2024 - Grant Avenue - Creo2024-12-31https://www.crosstreecapital.com/deals/medavante-acquired-by-arsenal-capital-partners-and-wcg-march-9-20172025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20212024-12-19https://www.crosstreecapital.com/insights/events/acmg2025-02-11https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-february-20252025-03-26https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20232024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20242024-12-19https://www.crosstreecapital.com/white-paper/precision-and-specialty-medicines-impact-on-the-future-of-clinical-trials2024-07-29https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-march-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20202024-12-19https://www.crosstreecapital.com/deals/prostalund-acquired-by-farstorp2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20232024-12-19https://www.crosstreecapital.com/case-study/crosstree-helps-archimed-create-early-drug-development-platform-through-three-way-acquisitionhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpgcrosstree-og-image-Jan-02-2024-04-39-57-4666-PMcrosstree-og-image-Jan-02-2024-04-39-57-4666-PM2024-01-09https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-april-20192024-12-19https://www.crosstreecapital.com/deals/csm-a-portfolio-company-of-great-point-partners-has-been-acquired-by-clinigen-september-20182025-01-22https://www.crosstreecapital.com/testimonialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/CC-Logo-2019-Horizontal-blue.pngCC-Logo-2019-Horizontal-blueCC-Logo-2019-Horizontal-bluehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/Trifecta-Logo.pngTrifecta-LogoTrifecta-Logohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/BioAgilytix-Logo-Hi-Res-e1616344833341-768x173.jpgBioAgilytix-Logo-Hi-Res-e1616344833341-768x173BioAgilytix-Logo-Hi-Res-e1616344833341-768x173https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/Enthalpy-p.jpgEnthalpy-pEnthalpy-phttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/array-768x134.jpgarray-768x134array-768x134https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Tim-Billington-Pharmasol.pngTim-Billington-PharmasolTim-Billington-Pharmasolhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/John-Winebarger_photo-circle.pngJohn-Winebarger_photo-circleJohn-Winebarger_photo-circlehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/Ascent-logo.pngAscent-logoAscent-logohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/download-1-e1633377000585.pngdownload-1-e1633377000585download-1-e1633377000585https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/pharmasol_logo-rgb-768x204.pngpharmasol_logo-rgb-768x204pharmasol_logo-rgb-768x204https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/integreviewlogo.pngintegreviewlogointegreviewlogohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Stanton%20Kawer%20-%20Continuum%20Clinical.pngStanton Kawer - Continuum ClinicalStanton Kawer - Continuum Clinicalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Client%20Testimonials.jpegClient TestimonialsClient Testimonialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Doug-Engfer-for-website.pngDoug-Engfer-for-websiteDoug-Engfer-for-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Jim-Petrilla-for-website.pngJim-Petrilla-for-websiteJim-Petrilla-for-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/invivodata.pnginvivodatainvivodatahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Soumitra-Chowdhury-website.pngSoumitra-Chowdhury-websiteSoumitra-Chowdhury-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Sandy-Ferber-Headshot-for-website-1.pngSandy-Ferber-Headshot-for-website-1Sandy-Ferber-Headshot-for-website-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Todd-Grosshandler-for-website.pngTodd-Grosshandler-for-websiteTodd-Grosshandler-for-website2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-february-20192024-12-19https://www.crosstreecapital.com/insightshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/BBK-Infographic.pngBBK-InfographicBBK-Infographichttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_299056404-A.webpAdobeStock_299056404-AAdobeStock_299056404-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_ZebraSci-2-scaled.jpgCrosstree_Tombstone_Infographic_ZebraSci-2-scaledCrosstree_Tombstone_Infographic_ZebraSci-2-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-28T163243.240.pngUntitled design - 2025-01-28T163243.240Untitled design - 2025-01-28T163243.240https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/deal.pngdealdealhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(4)-1.pngUntitled design (4)-1Untitled design (4)-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-MBR-Social-Sized-1.pngDeal-Campaign-Infographic-MBR-Social-Sized-1Deal-Campaign-Infographic-MBR-Social-Sized-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/DT-July-BB-Website-Image.pngDT-July-BB-Website-ImageDT-July-BB-Website-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Lexitas-NovaQuest-Deal-Infographic_Final.pngLexitas-NovaQuest-Deal-Infographic_FinalLexitas-NovaQuest-Deal-Infographic_Finalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T103632.637.pngUntitled design - 2025-04-16T103632.637Untitled design - 2025-04-16T103632.637https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-D.jpgshutterstock_1351392818-Dshutterstock_1351392818-Dhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(46)-1.pngUntitled design (46)-1Untitled design (46)-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-31T132859.166.pngUntitled design - 2025-03-31T132859.166Untitled design - 2025-03-31T132859.166https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-22T150033.284.pngUntitled design - 2025-04-22T150033.284Untitled design - 2025-04-22T150033.284https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/ROI%20Healthcare%20Deal%20Featured%20Image%20(1).pngROI Healthcare Deal Featured Image (1)ROI Healthcare Deal Featured Image (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-07T163307.697.pngUntitled design - 2025-01-07T163307.697Untitled design - 2025-01-07T163307.697https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-4.pngCopy-of-Untitled-Design-4Copy-of-Untitled-Design-4https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_424161376-1800x1135.jpgshutterstock_424161376-1800x1135shutterstock_424161376-1800x1135https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-3.pngUntitled-design-3Untitled-design-3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpgcrosstree-og-image-Jan-02-2024-04-42-06-5457-PMcrosstree-og-image-Jan-02-2024-04-42-06-5457-PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-B.jpgshutterstock_1351392818-Bshutterstock_1351392818-Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(43).pngUntitled design (43)Untitled design (43)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-1-1.pngUntitled-design-1-1Untitled-design-1-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_423930893-C.jpgAdobeStock_423930893-CAdobeStock_423930893-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_238307387-B.webpAdobeStock_238307387-BAdobeStock_238307387-Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/PS-July-BB-Website-Image-1.pngPS-July-BB-Website-Image-1PS-July-BB-Website-Image-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_ClinChoice-01.pngCrosstree_Tombstone_Infographic_ClinChoice-01Crosstree_Tombstone_Infographic_ClinChoice-01https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpggraph-Jan-02-2024-04-42-10-7464-PMgraph-Jan-02-2024-04-42-10-7464-PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-VaxTRIALS-Social-Sized.pngDeal-Campaign-Infographic-VaxTRIALS-Social-SizedDeal-Campaign-Infographic-VaxTRIALS-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-26T160935.661.pngUntitled design - 2025-03-26T160935.661Untitled design - 2025-03-26T160935.661https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1752872030-1800x1200.jpgshutterstock_1752872030-1800x1200shutterstock_1752872030-1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_240748820-scaled.jpegAdobeStock_240748820-scaledAdobeStock_240748820-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1549204658-scaled.jpgshutterstock_1549204658-scaledshutterstock_1549204658-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1014555526-A.jpgshutterstock_1014555526-Ashutterstock_1014555526-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-04T165415.322.pngUntitled design - 2024-11-04T165415.322Untitled design - 2024-11-04T165415.322https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T082215.822.pngUntitled design - 2025-01-21T082215.822Untitled design - 2025-01-21T082215.822https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_534465133-4.jpgshutterstock_534465133-4shutterstock_534465133-4https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/images13.jpgimages13images13https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1884612880-A.jpgshutterstock_1884612880-Ashutterstock_1884612880-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design.pngCopy-of-Untitled-DesignCopy-of-Untitled-Designhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_469364276-B.jpgAdobeStock_469364276-BAdobeStock_469364276-Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-43.pngUntitled-design-43Untitled-design-43https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-C.jpgshutterstock_1351392818-Cshutterstock_1351392818-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-10-15T150559.010.pngUntitled design - 2024-10-15T150559.010Untitled design - 2024-10-15T150559.010https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_356099396-C.jpgAdobeStock_356099396-CAdobeStock_356099396-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Whitepaper%20PAO%20-%20Website%20Thumbnail%20Image.pngWhitepaper PAO - Website Thumbnail ImageWhitepaper PAO - Website Thumbnail Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(50).pngUntitled design (50)Untitled design (50)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_238307387-A.jpgAdobeStock_238307387-AAdobeStock_238307387-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-A.jpgshutterstock_1348356479-Ashutterstock_1348356479-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_293953008-1798x1200.jpegAdobeStock_293953008-1798x1200AdobeStock_293953008-1798x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstre_Tombstone_Infographic_Pyxant_Labcorp-2.pngCrosstre_Tombstone_Infographic_Pyxant_Labcorp-2Crosstre_Tombstone_Infographic_Pyxant_Labcorp-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-14T103931.881.pngUntitled design - 2025-04-14T103931.881Untitled design - 2025-04-14T103931.881https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-B.jpgshutterstock_1348356479-Bshutterstock_1348356479-Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-52.pngUntitled-design-52Untitled-design-52https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb-2021-ContentFeb-2021-Contenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrows_Orange2Arrows_Orange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-26T103716.855.pngUntitled design - 2024-11-26T103716.855Untitled design - 2024-11-26T103716.855https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Yecuris%20Deal%20Insight.pngThumbnail Yecuris Deal InsightThumbnail Yecuris Deal Insighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20(1200%20x%201200%20px)%20(1).pngUntitled (1200 x 1200 px) (1)Untitled (1200 x 1200 px) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-26T102948.498.pngUntitled design - 2024-11-26T102948.498Untitled design - 2024-11-26T102948.498https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Excel.pngCrosstree_Tombstone_Infographic_ExcelCrosstree_Tombstone_Infographic_Excelhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_94798635-1.jpgAdobeStock_94798635-1AdobeStock_94798635-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(64).pngUntitled design (64)Untitled design (64)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-33.pngUntitled-design-33Untitled-design-33https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_281211016-1800x1009.jpegAdobeStock_281211016-1800x1009AdobeStock_281211016-1800x1009https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_UpStream-1.jpgCrosstree_Tombstone_Infographic_UpStream-1Crosstree_Tombstone_Infographic_UpStream-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/RMC-Deal-Infographic-Featured-Image.pngRMC-Deal-Infographic-Featured-ImageRMC-Deal-Infographic-Featured-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/BB%20D&T%20-%20February%202024.pngBB D&T - February 2024BB D&T - February 2024https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Anteris-featured-image.pngCrosstree_Tombstone_Infographic_Anteris-featured-imageCrosstree_Tombstone_Infographic_Anteris-featured-imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(72).pngUntitled design (72)Untitled design (72)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-26T161312.897.pngUntitled design - 2025-03-26T161312.897Untitled design - 2025-03-26T161312.897https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T083456.357.pngUntitled design - 2025-01-21T083456.357Untitled design - 2025-01-21T083456.357https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/CSSi-PAG-Infographic-featured-image.pngCSSi-PAG-Infographic-featured-imageCSSi-PAG-Infographic-featured-imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/white-papers/Positioning-Biobanking-Assets-for-Maximum-Value-Cover.jpegPositioning-Biobanking-Assets-for-Maximum-Value-CoverPositioning-Biobanking-Assets-for-Maximum-Value-Coverhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Protocol-First_Infographic-01-1-scaled.jpgCrosstree_Protocol-First_Infographic-01-1-scaledCrosstree_Protocol-First_Infographic-01-1-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(42).pngUntitled design (42)Untitled design (42)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-Versiti-Pearl-Pathways-Social-Sized.pngDeal-Campaign-Infographic-Versiti-Pearl-Pathways-Social-SizedDeal-Campaign-Infographic-Versiti-Pearl-Pathways-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-26T112228.581.pngUntitled design - 2025-02-26T112228.581Untitled design - 2025-02-26T112228.581https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-GrantCREO-Social-Sized.pngDeal-Campaign-Infographic-GrantCREO-Social-SizedDeal-Campaign-Infographic-GrantCREO-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/BCT-Deal-Infographic-Featured-Image.pngBCT-Deal-Infographic-Featured-ImageBCT-Deal-Infographic-Featured-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_238307387-C.jpgAdobeStock_238307387-CAdobeStock_238307387-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Ascent-Pharmalex.pngAscent-PharmalexAscent-Pharmalexhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(29).pngUntitled design (29)Untitled design (29)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Open-Clinica_Infographic-1.pngCrosstree_Open-Clinica_Infographic-1Crosstree_Open-Clinica_Infographic-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-17T150049.946.pngUntitled design - 2025-03-17T150049.946Untitled design - 2025-03-17T150049.946https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-06T120438.784.pngUntitled design - 2025-01-06T120438.784Untitled design - 2025-01-06T120438.784https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_IRB_Infographic_vF.pngCrosstree_IRB_Infographic_vFCrosstree_IRB_Infographic_vFhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-03T122043.440.pngUntitled design - 2025-03-03T122043.440Untitled design - 2025-03-03T122043.440https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_CTT-scaled.jpgCrosstree_Tombstone_Infographic_CTT-scaledCrosstree_Tombstone_Infographic_CTT-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T093744.809.pngUntitled design - 2025-01-21T093744.809Untitled design - 2025-01-21T093744.809https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-51.pngUntitled-design-51Untitled-design-51https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Navitas_Infographic-v2-featured-image-1.pngCrosstree_Navitas_Infographic-v2-featured-image-1Crosstree_Navitas_Infographic-v2-featured-image-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-24T143232.742.pngUntitled design - 2025-02-24T143232.742Untitled design - 2025-02-24T143232.742https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1242847558-768x512.jpgshutterstock_1242847558-768x512shutterstock_1242847558-768x512https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-A.jpgshutterstock_1351392818-Ashutterstock_1351392818-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-2.pngCopy-of-Untitled-Design-2Copy-of-Untitled-Design-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_201606393-1800x1013.jpegAdobeStock_201606393-1800x1013AdobeStock_201606393-1800x1013https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpggraph-Jan-02-2024-04-40-03-6178-PMgraph-Jan-02-2024-04-40-03-6178-PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(40).pngUntitled design (40)Untitled design (40)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/PS-July-BB-Website-Image-2.pngPS-July-BB-Website-Image-2PS-July-BB-Website-Image-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Untitled-design-22.pngUntitled-design-22Untitled-design-22https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-26T160124.257.pngUntitled design - 2025-03-26T160124.257Untitled design - 2025-03-26T160124.257https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpgcrosstree-og-image-Jan-02-2024-04-39-57-4666-PMcrosstree-og-image-Jan-02-2024-04-39-57-4666-PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-3.pngCopy-of-Untitled-Design-3Copy-of-Untitled-Design-3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_240395963-1-1800x1200.jpegAdobeStock_240395963-1-1800x1200AdobeStock_240395963-1-1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-04T164958.577.pngUntitled design - 2024-11-04T164958.577Untitled design - 2024-11-04T164958.577https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-26T112246.466.pngUntitled design - 2025-02-26T112246.466Untitled design - 2025-02-26T112246.466https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(69).pngUntitled design (69)Untitled design (69)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/LVC-and-Summit-Infographic-Featured-Image.pngLVC-and-Summit-Infographic-Featured-ImageLVC-and-Summit-Infographic-Featured-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-QDx-Social-Sized.pngDeal-Campaign-Infographic-QDx-Social-SizedDeal-Campaign-Infographic-QDx-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Sabai-Infographic_featured-image.pngSabai-Infographic_featured-imageSabai-Infographic_featured-imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-1.pngCopy-of-Untitled-Design-1Copy-of-Untitled-Design-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle-2NewArticle-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1884612880-B.jpgshutterstock_1884612880-Bshutterstock_1884612880-Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_275264857-1800x1013.webpAdobeStock_275264857-1800x1013AdobeStock_275264857-1800x1013https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/PS-July-BB-Website-Image.pngPS-July-BB-Website-ImagePS-July-BB-Website-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism-1800x1200Prism-1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/white-papers/Precision-and-Specialty-Medicine-Clinical-Trial-White-Paper-Cover-Image.jpegPrecision-and-Specialty-Medicine-Clinical-Trial-White-Paper-Cover-ImagePrecision-and-Specialty-Medicine-Clinical-Trial-White-Paper-Cover-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Pharma%20Blue%20Book%20-%20February%202024.jpgPharma Blue Book - February 2024Pharma Blue Book - February 2024https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Grenova-Infographic-Image.pngGrenova-Infographic-ImageGrenova-Infographic-Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Alpha%20IRB%20Deal%20Insight.pngThumbnail Alpha IRB Deal InsightThumbnail Alpha IRB Deal Insighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/crosstree-tombstone-infographic-thumbnail-2.pngcrosstree-tombstone-infographic-thumbnail-2crosstree-tombstone-infographic-thumbnail-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-01T154859.733.pngUntitled design - 2025-04-01T154859.733Untitled design - 2025-04-01T154859.733https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-34-1.pngUntitled-design-34-1Untitled-design-34-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(49).pngUntitled design (49)Untitled design (49)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Benchmark.pngCrosstree_Tombstone_Infographic_BenchmarkCrosstree_Tombstone_Infographic_Benchmarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(19)-1.pngUntitled design (19)-1Untitled design (19)-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(26).pngUntitled design (26)Untitled design (26)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_982679813.jpegAdobeStock_982679813AdobeStock_982679813https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(51).pngUntitled design (51)Untitled design (51)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-SSI-Strategy-Social-Sized.pngDeal-Campaign-Infographic-SSI-Strategy-Social-SizedDeal-Campaign-Infographic-SSI-Strategy-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(10).pngUntitled design (10)Untitled design (10)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(1).pngUntitled design (1)Untitled design (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T083007.436.pngUntitled design - 2025-01-21T083007.436Untitled design - 2025-01-21T083007.436https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/white-papers/Inorganic-Growth-Strategies-in-Precision-Medicine-White-Paper-Cover.jpegInorganic-Growth-Strategies-in-Precision-Medicine-White-Paper-CoverInorganic-Growth-Strategies-in-Precision-Medicine-White-Paper-Coverhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Catalyst-Genpro.pngCrosstree_Tombstone_Infographic_Catalyst-GenproCrosstree_Tombstone_Infographic_Catalyst-Genprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpegcrosstree-og-image-Jan-02-2024-04-39-57-4666-PMcrosstree-og-image-Jan-02-2024-04-39-57-4666-PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRick-Riegel-Still-2Rick-Riegel-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Continuum%20Clinical%20Deal%20Insight.pngThumbnail Continuum Clinical Deal InsightThumbnail Continuum Clinical Deal Insighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_46595127.jpgAdobeStock_46595127AdobeStock_46595127https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-10-17T145851.189.pngUntitled design - 2024-10-17T145851.189Untitled design - 2024-10-17T145851.189https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Infographic-Versiti.pngDeal-Insight-Campaign-Infographic-VersitiDeal-Insight-Campaign-Infographic-Versitihttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-42.pngUntitled-design-42Untitled-design-42https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_233911676-1800x1200.webpAdobeStock_233911676-1800x1200AdobeStock_233911676-1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-05T092022.185.pngUntitled design - 2024-09-05T092022.185Untitled design - 2024-09-05T092022.185https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-C.jpgshutterstock_1348356479-Cshutterstock_1348356479-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/PreventionGenetics-Infographic.pngPreventionGenetics-InfographicPreventionGenetics-Infographichttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1014555526-C.jpgshutterstock_1014555526-Cshutterstock_1014555526-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Modular%20Devices%20Deal%20Insight.pngThumbnail Modular Devices Deal InsightThumbnail Modular Devices Deal Insighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-28T173343.495.pngUntitled design - 2025-02-28T173343.495Untitled design - 2025-02-28T173343.495https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(48).pngUntitled design (48)Untitled design (48)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Benchmark-v2-2.pngCrosstree_Tombstone_Infographic_Benchmark-v2-2Crosstree_Tombstone_Infographic_Benchmark-v2-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-13T113514.444.pngUntitled design - 2025-03-13T113514.444Untitled design - 2025-03-13T113514.444https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Pharmica-scaled.jpgCrosstree_Tombstone_Infographic_Pharmica-scaledCrosstree_Tombstone_Infographic_Pharmica-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_356099396-A.webpAdobeStock_356099396-AAdobeStock_356099396-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-B-1.jpgshutterstock_1348356479-B-1shutterstock_1348356479-B-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-04T092707.128.pngUntitled design - 2024-09-04T092707.128Untitled design - 2024-09-04T092707.128https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T110543.792.pngUntitled design - 2025-04-16T110543.792Untitled design - 2025-04-16T110543.792https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_469364276-A-1.jpgAdobeStock_469364276-A-1AdobeStock_469364276-A-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_534465133-3.jpgshutterstock_534465133-3shutterstock_534465133-3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1014555526-B.jpgshutterstock_1014555526-Bshutterstock_1014555526-Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(2)-1.pngUntitled design (2)-1Untitled design (2)-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-12-30T172014.577.pngUntitled design - 2024-12-30T172014.577Untitled design - 2024-12-30T172014.577https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Pharmasol-smaller.jpgCrosstree_Tombstone_Infographic_Pharmasol-smallerCrosstree_Tombstone_Infographic_Pharmasol-smallerhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-53.pngUntitled-design-53Untitled-design-53https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-D.jpgshutterstock_1348356479-Dshutterstock_1348356479-Dhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-05T091738.213.pngUntitled design - 2024-09-05T091738.213Untitled design - 2024-09-05T091738.213https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1054265696_small.jpgshutterstock_1054265696_smallshutterstock_1054265696_smallhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Quartesian_Summit-scaled.jpgCrosstree_Tombstone_Infographic_Quartesian_Summit-scaledCrosstree_Tombstone_Infographic_Quartesian_Summit-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-06T121211.560.pngUntitled design - 2025-01-06T121211.560Untitled design - 2025-01-06T121211.560https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_280738306-C.jpgAdobeStock_280738306-CAdobeStock_280738306-Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree-Deal-Insight-Infographic-Featured-Image-RealTime.pngCrosstree-Deal-Insight-Infographic-Featured-Image-RealTimeCrosstree-Deal-Insight-Infographic-Featured-Image-RealTimehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_dMed_Infographic-v3-scaled.jpgCrosstree_dMed_Infographic-v3-scaledCrosstree_dMed_Infographic-v3-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovations-Book-Feature-Image-for-website-1-scaledInnovations-Book-Feature-Image-for-website-1-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_469364276-A.jpgAdobeStock_469364276-AAdobeStock_469364276-Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_CCRC-01.jpgCrosstree_Tombstone_Infographic_CCRC-01Crosstree_Tombstone_Infographic_CCRC-01https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/no-challenges-thumbnail.jpgno-challenges-thumbnailno-challenges-thumbnail2024-12-31https://www.crosstreecapital.com/articlehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb-2021-ContentFeb-2021-Contenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrows_Orange2Arrows_Orange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle-2NewArticle-22024-01-03https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-december-20202024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20222024-12-19https://www.crosstreecapital.com/about/teamhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jason-Layton-Website.jpgJason-Layton-WebsiteJason-Layton-Websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Gregory%20Bare_tie_color.jpgGregory Bare_tie_colorGregory Bare_tie_colorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Gordon-Ryerson-Website-1.jpgGordon-Ryerson-Website-1Gordon-Ryerson-Website-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Dan%20Niswonger_tie_color.jpgDan Niswonger_tie_colorDan Niswonger_tie_colorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Sara%20Casamiento%20website.pngSara Casamiento websiteSara Casamiento websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Dominic-Stockey-Website.jpgDominic-Stockey-WebsiteDominic-Stockey-Websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jeff-Ellis-Website.jpgJeff-Ellis-WebsiteJeff-Ellis-Websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Cason-Searan_tie_Color-website.jpgCason-Searan_tie_Color-websiteCason-Searan_tie_Color-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Anne-Juarez-website.jpgAnne-Juarez-websiteAnne-Juarez-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstree_bg_abstractcrosstree_bg_abstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Shane-Senior-Website-2.jpgShane-Senior-Website-2Shane-Senior-Website-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Ben%20Garber_Color.jpgBen Garber_ColorBen Garber_Colorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Mike%20Levin_tie_color.jpgMike Levin_tie_colorMike Levin_tie_colorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Stacey%20Troxell_Headshot%20-%20for%20website.jpgStacey Troxell_Headshot - for websiteStacey Troxell_Headshot - for website2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-january-20192024-12-19https://www.crosstreecapital.com/insights/events/global-site-solutions-summit2024-12-31https://www.crosstreecapital.com/deals/scandius-biomedical-amount-raised-undisclosed-preferred-equity-placement-agent2025-01-22https://www.crosstreecapital.com/insights/events/dia-eu2025-02-11https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-november-20202024-12-19https://www.crosstreecapital.com/deals/critical-path-service-acquired-by-knoell-june-13-20132025-01-22https://www.crosstreecapital.com/market-maphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovations-Book-Feature-Image-for-website-1-scaledInnovations-Book-Feature-Image-for-website-1-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism-1800x1200Prism-1800x12002024-01-09https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20202024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-may-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-december-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-july-20192024-12-19https://www.crosstreecapital.com/deals/wcg-leonardgreenpartners2025-01-22https://www.crosstreecapital.com/insights/events/lp/aacr2025-03-19https://www.crosstreecapital.com/insights/events/lp/ashg-annual-meeting2024-10-01https://www.crosstreecapital.com/careershttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/Crosstree%20Recruitment%20Video%20V5.mp4/medium.jpgCrosstree Recruitment Video V5Crosstree Recruitment Video V5https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/Crosstree%20Recruitment%20Video%20V5.mp4225nonohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jason-Layton-Website.jpgJason-Layton-WebsiteJason-Layton-Websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Director%20Platform%20Top.jpgDirector Platform TopDirector Platform Tophttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Authenticity.jpegAuthenticityAuthenticityhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Life%20at%20Crosstree.jpgLife at CrosstreeLife at Crosstreehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Dominic-Stockey-Website.jpgDominic-Stockey-WebsiteDominic-Stockey-Websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jeff-Ellis-Website.jpgJeff-Ellis-WebsiteJeff-Ellis-Websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Anne-Juarez-website.jpgAnne-Juarez-websiteAnne-Juarez-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Excellence.jpgExcellenceExcellencehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Careers%20Homepage.jpgCareers HomepageCareers Homepagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Marvin-Best_tie_color_for-website.jpgMarvin-Best_tie_color_for-websiteMarvin-Best_tie_color_for-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Exceptional%20Outcomes.jpgExceptional OutcomesExceptional Outcomes2024-12-31https://www.crosstreecapital.com/insights/events/lp/cphi-worldwide2024-09-09https://www.crosstreecapital.com/deals/rmc-pharmaceutical-solutions-acquired-by-syner-g-biopharma-group-a-portfolio-company-of-riverside-partners-to-expand-regulatory-compliance-solutions2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20212024-12-19https://www.crosstreecapital.com/deals/endpoint-received-a-strategic-investment-from-chiltern-march-31-20102025-01-22https://www.crosstreecapital.com/insights/events/chime-innovation-summit-southeast2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you2024-02-14https://www.crosstreecapital.com/deals/sabai-global-acquired-by-thompson-street-capital-partners-to-accelerate-ibc-and-irb-growth2025-01-22https://www.crosstreecapital.com/deals/qdx-pathology-a-portfolio-company-of-hadley-capital-acquired-by-labgenomics-to-expand-esoteric-testing-capabilities-globally2025-01-22https://www.crosstreecapital.com/deals/paragon-biomedical-acquired-by-clinipace-worldwide-september-25-20122025-01-22https://www.crosstreecapital.com/market-map/innovations-in-pharmaceutical-developmenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovations-Book-Feature-Image-for-website-1-scaledInnovations-Book-Feature-Image-for-website-1-scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism-1800x1200Prism-1800x12002024-01-09https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-february-20252025-03-31https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-february-20252025-04-01https://www.crosstreecapital.com/deals/integreview-was-acquired-by-advarra2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-november-20192024-12-19https://www.crosstreecapital.com/white-paper/inorganic-growth-strategies-in-precision-medicine2024-07-29https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20242025-01-21https://www.crosstreecapital.com/deals/navinet-amount-raised-undisclosed-senior-debt-by-a-placement-agent2025-01-22https://www.crosstreecapital.com/deals/monroe-biomedical-research-acquired-by-new-harbor-capital-in-a-first-step-to-build-out-a-clinical-research-site-platform2025-01-22https://www.crosstreecapital.com/focus/diagnostics-and-toolshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDeal Insight Tombstone BiotechneDeal Insight Tombstone Biotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20HistoGeneX%20-%20Arsenal.png2024 - HistoGeneX - Arsenal2024 - HistoGeneX - Arsenalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Prevention%20Genetics%20-%20Exact%20Sciences.png2024 - Prevention Genetics - Exact Sciences2024 - Prevention Genetics - Exact Scienceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20MoledcularMD%20-%20ICON.png2024 - MoledcularMD - ICON2024 - MoledcularMD - ICONhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDeal Insight Campaign Tombstone - BBIIBEXDeal Insight Campaign Tombstone - BBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Expertise-D&T.jpgExpertise-D&TExpertise-D&Thttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_heart.svgicon_hearticon_hearthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Santus%20-%20Reliable.png2024 - Santus - Reliable2024 - Santus - Reliablehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_clipboard-1.svgicon_clipboard-1icon_clipboard-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_brain.svgicon_brainicon_brainhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Quantizen.png2024 - Versiti - Quantizen2024 - Versiti - Quantizenhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Access%20-%20Aries.png2024 - Access - Aries2024 - Access - Arieshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20PhenoPath%20-%20Quest%20Diagnostics%20(1).png2024 - PhenoPath - Quest Diagnostics (1)2024 - PhenoPath - Quest Diagnostics (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pyxant%20Labs%20-%20Covance.png2024 - Pyxant Labs - Covance2024 - Pyxant Labs - Covancehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pyxant%20Labs%20-%20ArchiMed.png2024 - Pyxant Labs - ArchiMed2024 - Pyxant Labs - ArchiMedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20QDX%20-%20Hadley%20-%20LabGenomics.png2024 - QDX - Hadley - LabGenomics2024 - QDX - Hadley - LabGenomicshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/D&T%20-%20BlueBook.jpegD&T - BlueBookD&T - BlueBookhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Zebrasci%20-%20BD.png2024 - Zebrasci - BD2024 - Zebrasci - BDhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDeal Insight Tombstone sengenics (2)Deal Insight Tombstone sengenics (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OpGen%20-%20Curetis.png2024 - OpGen - Curetis2024 - OpGen - Curetishttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Transposagen%20-%20Lonza.png2024 - Transposagen - Lonza2024 - Transposagen - Lonzahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_heart-hands.svgicon_heart-handsicon_heart-handshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_660603214.jpegAdobeStock_660603214AdobeStock_660603214https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grant%20Avenue%20-%20Creo.png2024 - Grant Avenue - Creo2024 - Grant Avenue - Creohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Santus%20-%20DermaRite.png2024 - Santus - DermaRite2024 - Santus - DermaRitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grenova%20-%20Peloton.png2024 - Grenova - Peloton2024 - Grenova - Pelotonhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Haematologic%20Technologies%20-%20Edgewater.png2024 - Haematologic Technologies - Edgewater2024 - Haematologic Technologies - Edgewater2024-12-31https://www.crosstreecapital.com/deals/omniseq-received-a-strategic-investment-from-labcorp-august-21-20172025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20242024-12-19https://www.crosstreecapital.com/videos/how-innovations-across-pharma-development-delivered-the-covid-19-vaccine-with-rick-ciminohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRick-Riegel-Still-2Rick-Riegel-Still-22024-01-09https://www.crosstreecapital.com/deals/longuevue-capital-partners-acquires-majority-stake-in-summit-clinical-research-to-accelerate-smo-iro-growth2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20232024-12-19https://www.crosstreecapital.com/insights/events/lp/dealmax2025-02-10https://www.crosstreecapital.com/deals/ancora-acquired-by-corden-pharma-november-12-20132025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20242025-01-21https://www.crosstreecapital.com/insights/events/world-drug-safety-congress-americas-20242024-12-31https://www.crosstreecapital.com/deals/arrowhead-acquired-by-medco-july-28-20112025-01-22https://www.crosstreecapital.com/deals/versiti-acquired-quantigen-to-further-expand-clinical-trial-expertise-and-service-offering2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20222024-12-19https://www.crosstreecapital.com/insights/events/lp/dpharm2024-09-09https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20242024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20222024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-february-20252025-03-26https://www.crosstreecapital.com/deals/sunlink-sold-assets-to-cvs-health2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-january-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20232024-12-19https://www.crosstreecapital.com/deals/pharmastar-acquired-by-ubc-april-21-20052025-01-22https://www.crosstreecapital.com/deals/dmed-acquired-clinipace2025-01-22https://www.crosstreecapital.com/deals/modular-devices-partners-with-flow-clean-room-and-supply2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-january-20252025-03-26https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-march-20192024-12-19https://www.crosstreecapital.com/deals/focus-pharmaceuticals-ltd-acquired-by-amco-october-1-20142025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-july-20192024-12-19https://www.crosstreecapital.com/white-paper/thank-you2024-02-14https://www.crosstreecapital.com/insights/events/thanks/world-vaccine-congress-europe2024-09-23https://www.crosstreecapital.com/insights/events/lp/world-vaccine-congress2025-04-08https://www.crosstreecapital.com/videos/future-of-clinical-trialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/no-challenges-thumbnail.jpgno-challenges-thumbnailno-challenges-thumbnailhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-01-09https://www.crosstreecapital.com/insights/events/thanks/beckers-healthcare-health-it-digital-health-rcm-conference2024-09-09https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2024-crosstree2025-01-21https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20232024-12-19https://www.crosstreecapital.com/insights/events/aaps2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-april-20192024-12-19https://www.crosstreecapital.com/deals/centralcoast-pathology-laboratory-business-acquired-by-sonic-healthcare-february-7-20112025-01-22https://www.crosstreecapital.com/deals/drugdev-acquired-by-quintilesims2025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-november-20242025-01-06https://www.crosstreecapital.com/careers/lifeatcrosstreehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Our%20Team.jpgOur TeamOur Teamhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Sports.jpgSportsSportshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Thriving.jpgThrivingThrivinghttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Life%20at%20Crosstree.jpgLife at CrosstreeLife at Crosstreehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/growing.jpggrowinggrowinghttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/active.jpgactiveactivehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Lifestyle.jpgLifestyleLifestylehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/best-beaches.jpgbest-beachesbest-beaches2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-20202024-12-19https://www.crosstreecapital.com/insights/events/snmmi2025-03-19https://www.crosstreecapital.com/about/team/shanesenior2025-04-15https://www.crosstreecapital.com/deals/protocol-first-joins-flatiron-health-to-help-bridge-the-gap-between-real-world-care-and-clinical-research2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-january-20252025-03-26https://www.crosstreecapital.com/insights/events/lp/chime-innovation-summit-southeast2025-03-19https://www.crosstreecapital.com/insights/events/thanks/tri-con2024-11-15https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20202024-12-19https://www.crosstreecapital.com/deals/worldcare-clinical-acquired-by-proscan-imaging-june-6-20062025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20232024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-january-20202024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20222024-12-19https://www.crosstreecapital.com/deals/medsphere-raised-12000000-of-senior-debt2025-01-22https://www.crosstreecapital.com/video2024-09-24https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20222024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-20222024-12-19https://www.crosstreecapital.com/insights/events/lp/asmebias-axs25-summit2025-03-19https://www.crosstreecapital.com/abouthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/hedgehog_2-2.mp4/medium.jpghedgehog_2-2hedgehog_2-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/hedgehog_2-2.mp425nonohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_authentic.svgicon_authenticicon_authentichttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_excellence.svgicon_excellenceicon_excellencehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/About%20-%20Envisioned%20Future.jpegAbout - Envisioned FutureAbout - Envisioned Futurehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_outcome.svgicon_outcomeicon_outcomehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstree_bg_abstractcrosstree_bg_abstract2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharma-technology-bluebook-march-20252025-04-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20232024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20222024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20222024-12-19https://www.crosstreecapital.com/article/precisionmedicinedrivinghttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle-2NewArticle-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrows_Orange2Arrows_Orange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb-2021-ContentFeb-2021-Contenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-01-04https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-february-20192024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20232024-12-19https://www.crosstreecapital.com/what-we-do/investment-banking-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/pharmasol_logo-rgb-768x204.pngpharmasol_logo-rgb-768x204pharmasol_logo-rgb-768x204https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/download-1-e1633377000585.pngdownload-1-e1633377000585download-1-e1633377000585https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-SizedDeal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDeal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)Deal Insight Campaign Tombstone - Yecuris (Social Sized) (NEW)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstone_ROI_01_28_2026-1Tombstone_ROI_01_28_2026-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Confident.jpgM&A - ConfidentM&A - Confidenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDeal Insight Campaign LVCCRCNJ - SocialDeal Insight Campaign LVCCRCNJ - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20QDX%20-%20Hadley%20-%20LabGenomics.png2024 - QDX - Hadley - LabGenomics2024 - QDX - Hadley - LabGenomicshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/John-Winebarger_photo-circle.pngJohn-Winebarger_photo-circleJohn-Winebarger_photo-circlehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Accelerate.jpgM&A - AccelerateM&A - Acceleratehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDeal Campaign Tombstone - PhysIQ (Social Sized) (1)Deal Campaign Tombstone - PhysIQ (Social Sized) (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDeal Insight Campaign Tombstone - Continuum Clinical (Social Sized)Deal Insight Campaign Tombstone - Continuum Clinical (Social Sized)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDeal Insight Tombstone sengenics (2)Deal Insight Tombstone sengenics (2)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDeal Insight Campaign Tombstone - BBIIBEXDeal Insight Campaign Tombstone - BBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Image.jpgM&A - ImageM&A - Imagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDeal Insight Campaign Myonex + Creapharm- Social V2Deal Insight Campaign Myonex + Creapharm- Social V2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDeal Insight Tombstone BiotechneDeal Insight Tombstone Biotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Process.jpgM&A - ProcessM&A - Processhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDeal Insight Campaign Myonex + Creapharm- Social V2 (1)Deal Insight Campaign Myonex + Creapharm- Social V2 (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Logos/Ascent%20logo.pngAscent logoAscent logohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20mbr%20-%20New%20harbor.png2024 - mbr - New harbor2024 - mbr - New harborhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep 6 AITempus (315 x 315 px)Deep 6 AITempus (315 x 315 px)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDeal Insight Tombstone iPeople (3)Deal Insight Tombstone iPeople (3)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDeal Insight Campaign LVCKerwin - SocialDeal Insight Campaign LVCKerwin - Socialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Tim-Billington-Pharmasol.pngTim-Billington-PharmasolTim-Billington-Pharmasolhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20Advisory.jpgM&A AdvisoryM&A Advisoryhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDeal Insight Tombstone ActiGraph (1)Deal Insight Tombstone ActiGraph (1)https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024 - Vax Trials - Emmes2024 - Vax Trials - Emmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Soumitra-Chowdhury-website.pngSoumitra-Chowdhury-websiteSoumitra-Chowdhury-websitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Higher%20Valuations.jpgM&A - Higher ValuationsM&A - Higher Valuationshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDeal Insight Tombstone Anju + ValsoftDeal Insight Tombstone Anju + Valsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDeal Insight Campaign Tombstone - Calyx (Social Sized).V3-1Deal Insight Campaign Tombstone - Calyx (Social Sized).V3-12024-02-15https://www.crosstreecapital.com/about/team/jeffellis2025-04-15https://www.crosstreecapital.com/insights/events/thanks/dia-eu2025-02-11https://www.crosstreecapital.com/insights/events/aacr2025-03-19https://www.crosstreecapital.com/videos/innovations-role-in-life-sciences-with-rick-riegelhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRick-Riegel-Still-2Rick-Riegel-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-22024-01-09https://www.crosstreecapital.com/deals/flourish-research-acquires-excel-medical-clinical-trials-to-expand-site-network-and-therapeutic-expertise2025-01-22https://www.crosstreecapital.com/deals/dynarand-acquired-by-ubc-april-21-20052025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20242024-12-19https://www.crosstreecapital.com/deals/imp-logistics-acquired-by-pra-and-genstar-capital-llc-march-4-20132025-01-22https://www.crosstreecapital.com/deals/imedex-acquired-by-amerisourcebergen-may-10-20042025-01-22https://www.crosstreecapital.com/deals/beacon-bioscience-acquired-by-icon-july-1-20042025-01-22https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-march-20252025-04-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-development-bluebook-january-20252025-03-26https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20222024-12-19https://www.crosstreecapital.com/deals/mpulse-mobile-acquired-message-beam-june-20182025-01-22https://www.crosstreecapital.com/white-paper/thank-you/inorganic-growth-strategies-in-precision-medicine2024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-april-20202024-12-19https://www.crosstreecapital.com/insights/events/pharma-ci-conference2024-12-31https://www.crosstreecapital.com/article/crosstree-in-pharmavoice-feb-2021https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle-2NewArticle-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrows_Orange2Arrows_Orange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb-2021-ContentFeb-2021-Content2024-01-09https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-20202024-12-19https://www.crosstreecapital.com/insights/events/thanks/acg-florida-capital-connection2024-11-12https://www.crosstreecapital.com/deals/zebrasci-acquired-by-bd-to-enhance-combination-product-testing-capabilities2025-01-22https://www.crosstreecapital.com/deals/anju-software-acquires-omnicomm-systems2025-01-22https://www.crosstreecapital.com/privacy-policyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstree_bg_abstractcrosstree_bg_abstract2024-02-14https://www.crosstreecapital.com/deals/omniseq-received-a-strategic-investment-from-hitachi-april-12-20182025-01-22https://www.crosstreecapital.com/deals/ccrc-recapitalized-by-martis-capital-via-its-newly-formed-clinical-research-site-platform-alcanza-clinical-research2025-01-22https://www.crosstreecapital.com/deals/predictive-biosciences-anatomic-pathology-business-acquired-by-miraca-life-sciences-november-19-20122025-01-22https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-april-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20232024-12-19https://www.crosstreecapital.com/insights/events/lp/ahima-24-conference2024-09-23https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-december-20242025-03-18https://www.crosstreecapital.com/videos/global-connectivity-and-pharma-development-innovation-with-steve-genshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRick-Cimino-Still-2Rick-Cimino-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteve-Gens-still-2Steve-Gens-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRick-Riegel-Still-2Rick-Riegel-Still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteve-Sullivan-still-2Steve-Sullivan-still-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_dark2024-01-09https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-august-20192024-12-19https://www.crosstreecapital.com/deals/pinnacle-clinical-research-a-portfolio-company-of-longvue-capital-acquires-kerwin-medical-center-to-bolster-clinical-trial-site-network-and-trial-execution-capabilities2025-01-22https://www.crosstreecapital.com/deals/bridge-laboratories-acquired-the-preclinical-testing-division-of-gene-logic-december-20-20062025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20242024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-20222024-12-19https://www.crosstreecapital.com/insights/events/aaps-national-biotechnology-conference2025-03-19https://www.crosstreecapital.com/deals/medlabs-diagnostics-recapitalized-by-caymus-equity-and-pnc-mezzanine-capital-april-3-20182025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-november-20242025-01-06https://www.crosstreecapital.com/deals/continuum-clinical-a-bc-worldwide-company-acquired-by-spectrum-science-a-portfolio-company-of-knox-lane-to-bolster-patient-engagement-capabilities2025-01-22https://www.crosstreecapital.com/deals/deep-6-ai-acquired-by-tempus2025-03-17https://www.crosstreecapital.com/deals/datalabs-acquired-broadpeak-november-7-20052025-01-22https://www.crosstreecapital.com/deals/sengenics-a-portfolio-company-of-summa-equity-acquired-by-standard-biotools2025-03-18https://www.crosstreecapital.com/deals/catalyst-clinical-research-a-portfolio-company-of-qhp-capital-acquired-genpro-research-to-expand-global-footprint-and-deepen-service-offerings2025-01-22https://www.crosstreecapital.com/deals/mediatech-acquired-by-corning-december-1-20112025-01-22https://www.crosstreecapital.com/insights/events/lp/pegs-europe2024-10-01https://www.crosstreecapital.com/deals/lexitas-acquired-by-novaquest-to-support-continued-growth-and-capability-expansion2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-december-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20232024-12-19https://www.crosstreecapital.com/deals/gsk-sold-assets-to-combe2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20202024-12-19https://www.crosstreecapital.com/insights/events/pegs-europe2024-12-31https://www.crosstreecapital.com/white-paper/thank-you/white-paperpatient-access-organizations-an-emerging-ecosystem2024-09-12https://www.crosstreecapital.com/deals/roi-healthcare-solutions-acquired-by-acuvance-a-portfolio-company-of-trinity-hunt2026-02-10https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-february-20192024-12-19https://www.crosstreecapital.com/insights/events/dpharm2024-12-31https://www.crosstreecapital.com/insights/events/thanks/himss2025-01-08https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20242024-12-19https://www.crosstreecapital.com/deals/primus-corporation-acquired-by-trinity-biotech-july-21-20052025-01-22https://www.crosstreecapital.com/insights/events/beckers-healthcare-health-it-digital-health-rcm-conference2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20192024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20242025-01-21https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20242025-01-21https://www.crosstreecapital.com/deals/myonex-acquired-creapharms-clinical-and-commercial-packaging-and-bioservices-business-units2025-01-22https://www.crosstreecapital.com/deals/gsk-sold-assets-to-lil-drug-store2025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20222024-12-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20242025-01-21https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20202024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-development-bluebook-march-20252025-04-14https://www.crosstreecapital.com/deals/actigraph-a-portfolio-company-of-archimed-acquired-biofourmis-life-science-business2025-03-13https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20232024-12-19https://www.crosstreecapital.com/white-paper/positioning-biobanking-assets-for-maximum-value2024-07-29https://www.crosstreecapital.com/deals/perrigo-advances-consumer-strategy-with-acquisition-of-prevacid24hr-from-gsk2025-01-22https://www.crosstreecapital.com/deals/american-diagnostica-acquired-by-sckisui-march-23-20092025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20212024-12-19https://www.crosstreecapital.com/deals/gq-life-sciences-acquired-by-aptean-october-3-20162025-01-22https://www.crosstreecapital.com/insights/events/thanks/cns-summit2024-11-01https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20212024-12-19https://www.crosstreecapital.com/deals/calyx-has-divested-its-enterprise-technology-division-to-ennov-to-enhance-ennovs-portfolio-of-eclinical-and-eregulatory-software-solutions2025-01-22https://www.crosstreecapital.com/deals/jubilant-organosys-ltd-acquired-target-research-associates-october-5-20052025-01-22https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20242025-01-21https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-sept-2019-22024-12-19https://www.crosstreecapital.com/business-continuityhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstree_bg_abstractcrosstree_bg_abstract2024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-development-bluebook-february-20252025-04-01https://www.crosstreecapital.com/insights/events/thanks/world-drug-safety-congress-americas-20242024-09-23https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-december-20242025-01-21https://www.crosstreecapital.com/about/team/bengarber2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20212024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20242024-12-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-april-20192024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20232024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-january-20202024-12-19https://www.crosstreecapital.com/about/team/mikelevin2025-04-15https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20242025-01-21https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20212024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20202024-12-19https://www.crosstreecapital.com/insights/events/thanks/sot2024-11-15https://www.crosstreecapital.com/insights/events/lp/cns-summit2024-11-01https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20222024-12-19https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20242024-12-19https://www.crosstreecapital.com/deals/hcs-acquired-by-girling2025-01-22https://www.crosstreecapital.com/careers/directorplatformhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/ownership-pie-chart2-768x538-1.jpgownership-pie-chart2-768x538-1ownership-pie-chart2-768x538-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Director%20Platform%20-%20SME.jpgDirector Platform - SMEDirector Platform - SMEhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/crosstree-heatmap-worldwide-768x538.jpgcrosstree-heatmap-worldwide-768x538crosstree-heatmap-worldwide-768x538https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/deal-size-pie-chart-02-768x538-1.jpgdeal-size-pie-chart-02-768x538-1deal-size-pie-chart-02-768x538-1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstree_bg_abstract_darkcrosstree_bg_abstract_darkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Director%20Platform%20Top.jpgDirector Platform TopDirector Platform Tophttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Rocket.jpgRocketRockethttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Advisor%20Execution%20Team.jpgAdvisor Execution TeamAdvisor Execution Team2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20242024-12-19https://www.crosstreecapital.com/insights/events/wrib2025-03-19https://www.crosstreecapital.com/insights/events/lp/scope-summit2024-11-01